Earnings Miss Has Canopy Growth on the Outside Looking in

Should investors buy Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) on the dip or heed the warnings the market is putting out today?

| More on:
Cannabis stocks have fallen.

Canopy Growth (TSX:WEED)(NYSE:CGC) had an impressive start to the year. Indeed, Canopy Growth saw its stock price increase from under $25 per share to start the year to more than $70 per share in February. A near-tripling in approximately one month is some pretty insane momentum indeed.

However, of late, shares of Canopy are back to trading below $30 per share. Accordingly, investors looking for hyper-growth stocks at more reasonable prices may be enticed by this stock right now.

Let’s discuss why the drop has taken place and whether loading up on Canopy stock right now is a good idea.

Fourth-quarter earnings failed to meet analysts’ estimates

For companies in incredibly high-growth segments such as cannabis, quarterly earnings mean more than for, say, a company that’s been around for 100 years and is operating in a mature industry, paying a large dividend. That’s because the company’s growth trajectory matters much more to investors that anything else.

This past quarter didn’t really get investors excited. Canopy Growth reported revenue of approximately $148 million. This amounted to a 38% growth rate year over year. That’s decent but really not what investors were hoping for. On a quarter-over-quarter basis, this only amounted to a 3% increase.

Additionally, Canopy Growth’s net loss during the quarter was a whopping $616 million. That’s more than four times what the company brought in in terms of revenue.

These losses are starting to pile up, and Canopy Growth’s $1.67 billion loss for this past fiscal year highlights the profitability concern many investors have with this stock. Yes, the majority of these losses were due to asset and inventory impairment charges. However, these impairment charges indicate the company’s relatively lax capital-allocation processes.

Accordingly, Canopy Growth is now in a position where it’s focusing more on cutting costs than generating growth. This sort of a situation obviously isn’t good for long-term growth investors in such stocks.

Bottom line

Canopy Growth’s financials are finally starting to bite investors on the behind.

Indeed, this company’s growth story has been overshadowed by its poor capital-allocation choices in the past. The company projects it will burn approximately $400 million next year and $125 million in 2023. That level of cash burn means investors are likely to wait three or more years to see positive cash flow materialize. That’s a heck of a lot longer than many initially expected.

Couple this reality with the fact that U.S. legalization may take a while to materialize, if at all, and there’s a tsunami of reasons to not jump into WEED stock quite yet.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »